BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16352531)

  • 21. The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry.
    Tokunaga K; Ikuta K; Adachi A; Matsuda M; Kurata T; Kojima A
    Virology; 1999 May; 257(2):285-9. PubMed ID: 10329538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis.
    Cosenza-Nashat MA; Kim MO; Zhao ML; Suh HS; Lee SC
    Brain Pathol; 2006 Oct; 16(4):256-65. PubMed ID: 17107594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nef proteins of distinct HIV-1 or -2 isolates differ in their binding properties for HCK: isolation of a novel Nef binding factor with characteristics of an adaptor protein.
    Karn T; Hock B; Holtrich U; Adamski M; Strebhardt K; Rübsamen-Waigmann H
    Virology; 1998 Jun; 246(1):45-52. PubMed ID: 9656992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection.
    Komuro I; Yokota Y; Yasuda S; Iwamoto A; Kagawa KS
    J Exp Med; 2003 Aug; 198(3):443-53. PubMed ID: 12900520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor.
    Trible RP; Emert-Sedlak L; Wales TE; Ayyavoo V; Engen JR; Smithgall TE
    J Mol Biol; 2007 Nov; 374(1):121-9. PubMed ID: 17920628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
    Hiipakka M; Poikonen K; Saksela K
    J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An SH3 binding motif within the nucleocapsid protein of porcine reproductive and respiratory syndrome virus interacts with the host cellular signaling proteins STAMI, TXK, Fyn, Hck, and cortactin.
    Kenney SP; Meng XJ
    Virus Res; 2015 Jun; 204():31-9. PubMed ID: 25882913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancement.
    Chutiwitoonchai N; Hiyoshi M; Mwimanzi P; Ueno T; Adachi A; Ode H; Sato H; Fackler OT; Okada S; Suzu S
    PLoS One; 2011; 6(11):e27696. PubMed ID: 22110726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a high-affinity artificial peptide.
    Stangler T; Tran T; Hoffmann S; Schmidt H; Jonas E; Willbold D
    Biol Chem; 2007 Jun; 388(6):611-5. PubMed ID: 17552908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dys-regulated activation of a Src tyroine kinase Hck at the Golgi disturbs N-glycosylation of a cytokine receptor Fms.
    Hassan R; Suzu S; Hiyoshi M; Takahashi-Makise N; Ueno T; Agatsuma T; Akari H; Komano J; Takebe Y; Motoyoshi K; Okada S
    J Cell Physiol; 2009 Nov; 221(2):458-68. PubMed ID: 19585521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nef alleles from all major HIV-1 clades activate Src-family kinases and enhance HIV-1 replication in an inhibitor-sensitive manner.
    Narute PS; Smithgall TE
    PLoS One; 2012; 7(2):e32561. PubMed ID: 22393415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation.
    Pecquet C; Nyga R; Penard-Lacronique V; Smithgall TE; Murakami H; Régnier A; Lassoued K; Gouilleux F
    Oncogene; 2007 Mar; 26(11):1577-85. PubMed ID: 16953222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
    Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
    J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions.
    Bouchet J; Hérate C; Guenzel CA; Vérollet C; Järviluoma A; Mazzolini J; Rafie S; Chames P; Baty D; Saksela K; Niedergang F; Maridonneau-Parini I; Benichou S
    J Virol; 2012 May; 86(9):4856-67. PubMed ID: 22345475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 Nef triggers macrophage fusion in a p61Hck- and protease-dependent manner.
    Vérollet C; Zhang YM; Le Cabec V; Mazzolini J; Charrière G; Labrousse A; Bouchet J; Medina I; Biessen E; Niedergang F; Bénichou S; Maridonneau-Parini I
    J Immunol; 2010 Jun; 184(12):7030-9. PubMed ID: 20488787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Nef-Induced Secretion of the Proinflammatory Protease TACE into Extracellular Vesicles Is Mediated by Raf-1 and Can Be Suppressed by Clinical Protein Kinase Inhibitors.
    Zhao Z; Fagerlund R; Baur AS; Saksela K
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts.
    Briggs SD; Smithgall TE
    J Biol Chem; 1999 Sep; 274(37):26579-83. PubMed ID: 10473622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck.
    Tokunaga K; Kiyokawa E; Nakaya M; Otsuka N; Kojima A; Kurata T; Matsuda M
    J Virol; 1998 Jul; 72(7):6257-9. PubMed ID: 9621101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.
    Saksela K; Cheng G; Baltimore D
    EMBO J; 1995 Feb; 14(3):484-91. PubMed ID: 7859737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities.
    Suzu S; Harada H; Matsumoto T; Okada S
    Blood; 2005 Apr; 105(8):3230-7. PubMed ID: 15626739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.